Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ASKA Pharmaceutical Holdings Co's Other Operating Expense for the
three
months ended in Mar. 2026 was 円6,897 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円28,538 Mil.
ASKA Pharmaceutical Holdings Co's quarterly Other Operating Expense
declined
from Sep. 2025 (円7,185 Mil) to Dec. 2025 (円7,079 Mil) and
declined
from Dec. 2025 (円7,079 Mil) to Mar. 2026 (円6,897 Mil).
ASKA Pharmaceutical Holdings Co's annual Other Operating Expense
increased
from Mar. 2024 (円24,164 Mil) to Mar. 2025 (円26,003 Mil) but then
declined
from Mar. 2025 (円26,003 Mil) to Mar. 2026 (円0 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円28,538 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of 円28,538 Mil mean?
ASKA Pharmaceutical Holdings Co (TSE:4886) has a Other Operating Expense of 円28,538 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on ASKA Pharmaceutical Holdings Co and its competitors.
Is ASKA Pharmaceutical Holdings Co's Other Operating Expense too high?
ASKA Pharmaceutical Holdings Co's current Other Operating Expense is 円28,538 Mil. Overall, ASKA Pharmaceutical Holdings Co has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ASKA Pharmaceutical Holdings Co's Other Operating Expense compare to ZTS?
ASKA Pharmaceutical Holdings Co's Other Operating Expense of 円28,538 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. ASKA Pharmaceutical Holdings Co's current Other Operating Expense is 円28,538 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASKA Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co (TSE:4886) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,428.71, compared to a current price of 円2,035.00 — trading 16.2% below its estimated fair value. The current Other Operating Expense is 円28,538 Mil. ASKA Pharmaceutical Holdings Co's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For ASKA Pharmaceutical Holdings Co (TSE:4886), the current Other Operating Expense is 円28,538 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ASKA Pharmaceutical Holdings Co (TSE:4886) Overvalued in 2026?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of 円2,035.00 is trading 16.2% below its estimated GF Value™ of 円2,428.71.
GuruFocus considers ASKA Pharmaceutical Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:4886:
Other Operating Expense: 円28,538 Mil
GF Value™: 円2,428.71 vs. price of 円2,035.00 (16.2% below fair value)
No single metric tells the full story. See the TSE:4886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and other related operations.
59GF Score
Get the complete analysis for TSE:4886
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4886 has been successfully added to your 
